<DOC>
	<DOCNO>NCT01946295</DOCNO>
	<brief_summary>Objective trial study famotidine add-on treatment effective placebo add-on reducing symptom schizophrenia among patient receive insufficient response ongoing antipsychotic treatment .</brief_summary>
	<brief_title>Famotidine Schizophrenia</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Famotidine</mesh_term>
	<criteria>ICD10 diagnosis schizophrenia ( F20.0020.39 , F20.5 , F20.9 ) disorder least 5 year disability pension . ( This mean treatment response satisfactory purpose study , subject potentially treatment resistant ) . Clinical Global Impression ( CGI ) severity score least 3 . No change schizophrenia treatment within 12 week study inclusion . Written inform consent The subject must fulfil schizophrenia criterion accord DSM IV ( 295.10 , .20 , .30 , .60 , .90 ) ( American Psychiatric association ) Research Diagnostic Criteria schizophrenia ( RDC ) [ 40 ] . They must also least mild residual symptom ( CGI 3 point ) . The DSMIV diagnosis verify use SCIDI [ 41 ] . The DSMIV clearly commonly use psychiatric research , important able generalize finding . However , several previous study use RDC , able compare result , diagnose patient accord system . Women childbearing age include use adequate contraception , otherwise verify subject pregnant ( sHCG ) , possibility pregnancy negligible ( e.g . personnel housing facility report person sexual relationship year ) subject approve remain sexually abstinent duration study . Epilepsy history unclear seizure , stroke , Parkinson 's disease , AIDS History substance addiction abuse within 3 month prior enrolment . Individuals deem risk aggressive behaviour suicide If laboratory test , EKG clinical observation warrant exclusion , exclude Women pregnant breastfeeding subject include study . Patients serious unstable physical illness also exclude Patients deem legally incapacitate accord Finnish Swedish law . Regular Uuse H2antagonists prescribe physician . Known allergy famotidine component interventional drug exclude . Ongoing treatment clozapine dixyrazine . Clinical condition `` much improve '' `` much improve '' , assess CGI , placebo leadin Renal insufficiency ( Pcreatinine within normal range . Glomerular filtration rate &lt; 30 ml/min accord CockcroftGault formula . ) Liver insufficiency ( SALAT elevate 2fold laboratory specific normal range )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>